Company: VEEV
Filing Date: 2025-05-05
Form Type: DEF 14A
Source: 0001140361-25-017353
Chunk: 34

Company: VEEVA SYSTEMS INC
Filing Date: 2025-05-05
Form: DEF 14A
Chunk 34
---
2025 Proxy Statement |

TABLE OF CONTENTS

Our Public Benefit Corporation Report Veeva Public Benefit Purpose (Part 1): Providing products and services that make the industries we serve more productive.

| • | Objective 1: Enable faster and less expensive clinical trials that are less burdensome and more accessible to patients |

| • | The Veeva Clinical Platform advances clinical trial execution by providing a complete and connected technology ecosystem. Our clinical platform is designed to enable seamless execution and flow of data between clinical trial stakeholders—including patients, research sites, contract research organizations (CROs), and trial sponsors—for faster, more efficient trials that achieve higher data accuracy and increased patient diversity. Our suite of applications for clinical research sites and patient engagement facilitates clinical trial participation for patients and streamlines study execution for research sites and trial sponsors. These offerings include applications that enable sites to manage study documents electronically and securely exchange information with sponsors and CROs. We take a long-term view and are working to fundamentally improve the burdensome clinical trial processes, not just sell products that are short-term fixes for short-term gain. |

Representative progress for fiscal 2025:

| • | Veeva Vault EDChas now been used in more than 1,400 clinical trials globally, bringing much-needed innovation to the industry, enabling faster clinical trial study builds, more efficient maintenance of the study protocol, and significant reduction in the effort of key data collection activities. Additionally, Veeva released the first-ever bi-directional, built-for-purposeSafety-to-EDCconnection, delivering a much-needed integration between sites and drug safety teams. This integration reduces the manual, out-of-the-system interactions between primary investigators and safety personnel, ensuring critical safety-related events are handled thoroughly and quickly. |

| • | We continue to invest inVeeva SiteVault. SiteVaultis a suite of applications—offered free for over 90% of clinical trial sites—that clinical trial sites use to manage their regulatory information and share information with clinical trial sponsors. The high-quality software and seamless integration of theSiteVaultsuite helps sites to be more efficient. More than 10,000 users actively useVeeva SiteVault. |

| • | We continue to introduce high-quality applications for clinical trial sites that help remove friction from the clinical trials process and make the industry overall more efficient. One example isVeevaID,which we introduced in our last fiscal year.VeevaIDprovides single sign-on capability for clinical researchers across all sponsor systems. Typical site users have six